Skip to main content
Premium Trial:

Request an Annual Quote

Paul Selvin, Daniel O’Day, Michael Onuscheck, Christophe Lambert, Francesca Demichelis

BioNanomatrix has appointed biophysicist Paul Selvin to its scientific advisory board, the firm said last week. Selvin is a professor of physics and biophysics at the University of Illinois at Urbana-Champaign.

The California Healthcare Institute said last week that it has elected Daniel O’Day and Michael Onuscheck to its board of directors.
O’Day is currently president and CEO at Roche Molecular Diagnostics in Pleasanton, Calif. Onuscheck is president of the neuromodulation division at Boston Scientific.
CHI is a non-profit public-policy research organization representing California’s academic institutions, and biotechnology, medical device, diagnostics, and pharmaceutical firms.

Christophe Lambert, CEO of software firm Golden Helix, will co-chair the Copy Number Variation Data Analysis Team within the Microarray Quality Control project’s Genome-Wide Association Working Group, Golden Helix said last week.
Lambert will join co-chair Francesca Demichelis of the Institute for Computational Biomedicine at Weill Cornell Medical College.
The CNV Data Analysis Team now has over 50 members and aims to identify the sources of variation in results of analysis of copy number data on whole-genome microarrays.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.